Hepatitis viruses - Heptatitis A, B, C, D and E, clinical features, epidemiology and lab diagnosis

Preview:

DESCRIPTION

This is a series of lectures on microbiology useful for undergraduate medical and paramedical students

Citation preview

HEPATITIS VIRUSES

Dr. Ashish V. JawarkarM.D. (Pathology)

Dr. Ashish Jawarkar Hepatitis viruses 2

Hepatitis Infection of liver Hepatitis viruses – A, B, C, D, E and G B – DNA virus All others – RNA viruses Cause icteric jaundice

Type A and E – food borne, feco oral route Type B and C – Blood borne, parenteral and

sexual routes

Dr. Ashish Jawarkar Hepatitis viruses 3

Hepatitis A

Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment

Dr. Ashish Jawarkar Hepatitis viruses 4

Epidemiology

Common in children Feco oral route – contaminated water

or milk Over crowding and poor sanitation Ingested, reaches intestine,

penetrates epithelium, reaches liver through blood

Dr. Ashish Jawarkar Hepatitis viruses 5

Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment

Dr. Ashish Jawarkar Hepatitis viruses 6

Clinical features

2-6 weeks incubation period – asymptomatic

Clinical symptoms – malaise, anorexia, nausea, vomitting and abdominal pain

Yellow urine

Dr. Ashish Jawarkar Hepatitis viruses 7

Dr. Ashish Jawarkar Hepatitis viruses 8

Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment

Dr. Ashish Jawarkar Hepatitis viruses 9

Lab diagnosis

Raised bilirubin in serum (indirect>direct)

Yellow urine – bilirubin present Demonstration of antibodies by ELISA

IgM – recent infection IgG – remote infection

Dr. Ashish Jawarkar Hepatitis viruses 10

Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment

Dr. Ashish Jawarkar Hepatitis viruses 11

Prophylaxis

Improved sanitation Vaccine is available Natural infection leads to life long

immunity

Dr. Ashish Jawarkar Hepatitis viruses 12

Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment

Dr. Ashish Jawarkar Hepatitis viruses 13

Treatment

No antiviral drug available Treatment is symptomatic

Dr. Ashish Jawarkar Hepatitis viruses 14

TYPE B HEPATITIS

Over 350 million HBV carriers in the world

One million die anually

Dr. Ashish Jawarkar Hepatitis viruses 15

Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment

Dr. Ashish Jawarkar Hepatitis viruses 16

Epidemiology

Hepatitis B virus structure

Dr. Ashish Jawarkar Hepatitis viruses 17

In the serum of Hep B patients we can see – Australia antigen or

Dr. Ashish Jawarkar Hepatitis viruses 18

Dane particle

Dr. Ashish Jawarkar Hepatitis viruses 19

Developed countries

Adolscents and young adults Infection occurs through

contaminated syringes and needles Drug addicts Homosexuals

Dr. Ashish Jawarkar Hepatitis viruses 20

Developing countries

Children Vertical transmission from mother to

baby Horizontal transmission among

infants and neonates

Dr. Ashish Jawarkar Hepatitis viruses 21

Everywhere

Razors, nail clippers, acupuncture, tatooing, circumscision, ear or nose piercing

Barbers, dentists and doctors may get infected

Dr. Ashish Jawarkar Hepatitis viruses 22

Carriers

Those who donot have symptoms but are HbsAg positive

Dr. Ashish Jawarkar Hepatitis viruses 23

Screening of blood donors

Compulsory

Dr. Ashish Jawarkar Hepatitis viruses 24

Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment

Dr. Ashish Jawarkar Hepatitis viruses 25

Clinical features

No symptoms in carriers Similar to HAV in acute phase

Dr. Ashish Jawarkar Hepatitis viruses 26

Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment

Dr. Ashish Jawarkar Hepatitis viruses 27

Lab diagnosis

Demonstration of viral antibodies and antigens in serum -

Dr. Ashish Jawarkar Hepatitis viruses 28

Dr. Ashish Jawarkar Hepatitis viruses 29

HBsAg infection IgM anti HBcAg recent

infection IgG anti HBcAg remote

infection HBeAg infective Anti HBsAg immunity after

vaccination

Dr. Ashish Jawarkar Hepatitis viruses 30

Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment

Dr. Ashish Jawarkar Hepatitis viruses 31

Prophylaxis

Avoid multiple partners Avoid drug abuse Use of disposable syringes and

needles Screening of Blood, organ and semen

donors Universal immunisation (vaccination)

Dr. Ashish Jawarkar Hepatitis viruses 32

Immunisation - Passive

administer HBIG (Hepatitis B immunoglobulin)

Administer soon after accidental exposure

Can be administered to baby born to a carrier mother

Dr. Ashish Jawarkar Hepatitis viruses 33

Active immunisation - vaccine

Consists of HBsAg particles Given as a routine to all babies

Dr. Ashish Jawarkar Hepatitis viruses 34

Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment

Dr. Ashish Jawarkar Hepatitis viruses 35

Treatment

Acute phase – no treatment required, patients recover

Chronic phase – become carriers, can give antivirals like lamivudine and adefovir to keep replication in check

Dr. Ashish Jawarkar Hepatitis viruses 36

Hepatitis C Virus

Also blood borne Most common cause of post

transfusion hepatitis in developed countries

Most common cause of post hepatitis – hepatocellular carcinoma

Dr. Ashish Jawarkar Hepatitis viruses 37

Hepatitis E virus

Feco oral route Second common cause of hepatitis

after hepatitis A in developing countries

Generally mild and self limiting illness Unusually high mortality (20-40 %) in

pregnancy

Dr. Ashish Jawarkar Hepatitis viruses 38

Recommended